Sendai, Japan

Takuya Saito

This inventor holds 1 USPTO granted patent. Top assignee: Kayaku Antibiotic Research Co., Ltd.. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takuya Saito. Retrieved from https://idiyas.com/inventor/takuya-saito-980sdcur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takuya Saito: Innovator in Antibiotic Research

Introduction

Takuya Saito is a prominent inventor based in Sendai, Japan. He has made significant contributions to the field of antibiotic research, particularly with his innovative work on a new antibiotic known as TS-0822. His dedication to advancing medical treatments has led to the development of effective therapeutic compositions.

Latest Patents

Takuya Saito holds 1 patent for his invention titled "Antibiotic TS-0822." This patent describes a prophylactic and therapeutic composition that is effective in the treatment of coccidiomycosis. The antibiotic TS-0822 represents a breakthrough in the fight against this serious fungal infection.

Career Highlights

Saito is associated with Kayaku Antibiotic Research Co., Ltd., where he has been instrumental in the development of new antibiotic therapies. His work has not only contributed to scientific knowledge but has also had a practical impact on patient care.

Collaborations

Throughout his career, Takuya Saito has collaborated with notable colleagues, including Nakao Ishida and Fumio Kitame. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Takuya Saito's contributions to antibiotic research, particularly with his invention of TS-0822, highlight his role as a key innovator in the medical field. His work continues to pave the way for advancements in the treatment of infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…